Goldman Sachs Adjusts PT on Molina Healthcare to $124 From $167, Maintains Neutral Rating

NodeGuardian · 2026-02-27T06:20:37+00:00

Goldman Sachs reduced its price target for Molina Healthcare from $167 to $124 while keeping a Neutral rating. This follows similar target adjustments by other institutions, reflecting changes in the managed healthcare market.

NodeGuardian

2026-02-27 06:20:37

Abstract generation in progress

Goldman Sachs has lowered its price target for Molina Healthcare (MOH) to $124 from $167, while maintaining a Neutral rating on the stock. This adjustment follows similar actions by other institutions like Deutsche Bank, Barclays, UBS, Cantor Fitzgerald, Jefferies, and TD Cowen, which have also recently reduced their price targets for Molina Healthcare. The company provides managed healthcare services primarily within Medicaid and Medicare programs, and through the health insurance marketplace, serving approximately 5.5 million members.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.